Piculet Biosciences is an international biotechnology company offering its powerful PICON® technology for creation and selection of synthetic oligonucleotide-based binders to academia, biotech- and pharmaceutical companies.
PICONS® are synthetic non-immunogenic versions of antibodies with low nanomolar affinity, high stability and scalable pharmacokinetics. Our team has a demonstrated long record of successfully developing synthetic binders.
Piculet’s services consist of developing PICONS® for use as research and development tool, and for therapeutic and diagnostic application on fee for service basis.
Piculet successfully generated effective binders for external partners within multiple indications. Partnerships are a key part of our business strategy and thus we are also actively seeking new partnerships with companies that are interested in licensing our proprietary technology and products.
Please let us know if you have questions and / or would like to receive more information.
You can call us at +31 71 33 222 00 or send an email to firstname.lastname@example.org
|Piculet Biosciences Leiden